James H Jorgensen
Overview
Explore the profile of James H Jorgensen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
4200
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Satlin M, Nicolau D, Humphries R, Kuti J, Campeau S, Lewis Ii J, et al.
Clin Infect Dis
. 2019 Sep;
70(6):1240-1246.
PMID: 31504338
Daptomycin is one of the few treatment options for infections caused by enterococci that are resistant to ampicillin and vancomycin, such as vancomycin-resistant Enterococcus faecium. The emergence and clinical significance...
2.
Rahman M, Nguyen S, McCullor K, King C, Jorgensen J, McShan W
Genome Biol Evol
. 2016 Sep;
8(11):3446-3459.
PMID: 27678123
Streptococcus anginosus is a member of the normal oral flora that can become a pathogen causing pyogenic infections in humans. The genome of daptomycin-resistant strain J4206, originally isolated from a...
3.
Moore M, Link-Gelles R, Schaffner W, Lynfield R, Holtzman C, Harrison L, et al.
Lancet Respir Med
. 2016 Mar;
4(5):399-406.
PMID: 26987984
Background: In 2010, 13-valent pneumococcal conjugate vaccine (PCV13) was licensed and recommended in the USA for prevention of invasive pneumococcal disease in children. Licensure was based on immunogenicity data comparing...
4.
Rahman M, Nguyen S, McCullor K, King C, Jorgensen J, McShan W
Genome Announc
. 2015 Dec;
3(6).
PMID: 26679576
Streptococcus anginosus is an opportunistic human pathogen that causes abscesses of the brain, liver, and other organs. Here, we announce the complete genome sequence of a clinically isolated strain of...
5.
Jorgensen J
J Pediatric Infect Dis Soc
. 2015 Dec;
1(2):169-70.
PMID: 26619173
No abstract available.
6.
Moore M, Link-Gelles R, Schaffner W, Lynfield R, Lexau C, Bennett N, et al.
Lancet Infect Dis
. 2015 Feb;
15(3):301-9.
PMID: 25656600
Background: In 2000, seven-valent pneumococcal conjugate vaccine (PCV7) was introduced in the USA and resulted in dramatic reductions in invasive pneumococcal disease (IPD) and moderate increases in non-PCV7 type IPD....
7.
Keenan J, Klugman K, McGee L, Vidal J, Chochua S, Hawkins P, et al.
J Infect Dis
. 2014 Oct;
211(6):988-94.
PMID: 25293366
Background: A clinical trial of mass azithromycin distributions for trachoma created a convenient experiment to test the hypothesis that antibiotic use selects for clonal expansion of preexisting resistant bacterial strains....
8.
Lewis 2nd J, Lepak A, Thompson 3rd G, Craig W, Andes D, Sabol-Dzintars K, et al.
Antimicrob Agents Chemother
. 2013 Dec;
58(3):1327-31.
PMID: 24323478
Inducible clindamycin resistance in beta-hemolytic streptococci remains an underrecognized phenomenon of unknown clinical significance. We performed an evaluation of inducible clindamycin resistance using an animal model as well as retrospectively...
9.
Cardile A, Briggs H, Burguete S, Herrera M, Wickes B, Jorgensen J
Diagn Microbiol Infect Dis
. 2013 Nov;
78(2):199-200.
PMID: 24268534
Carbapenem-resistant Enterobacteriaceae infections are becoming more common, are associated with high mortality rates, and are difficult to treat due to multiple mechanisms of resistance. We describe the successful treatment of...
10.
Lewis 2nd J, Wiederhold N, Wickes B, Patterson T, Jorgensen J
Antimicrob Agents Chemother
. 2013 Jul;
57(9):4559-61.
PMID: 23817368
We report a case of Candida glabrata candidemia that developed resistance to micafungin within 8 days of initiation of therapy in a patient without previous echinocandin exposure or other known...